Inebilizumab
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Inebilizumab, covering 2019-12-26 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG) [Phase 2]